Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | SYS6002 |
Synonyms | |
Therapy Description |
SYS6002 (CRB-701) is an antibody-drug conjugate (ADC) targeting NECTIN4, which potentially decreases tumor growth (J Clin Oncol 42, no. 4_suppl (2024) 622). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
SYS6002 | SYS-6002|SYS 6002|CRB701|CRB-701|CRB 701 | SYS6002 (CRB-701) is an antibody-drug conjugate (ADC) targeting NECTIN4, which potentially decreases tumor growth (J Clin Oncol 42, no. 4_suppl (2024) 622). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06265727 | Phase Ib/II | SYS6002 | A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors | Recruiting | USA | GBR | ESP | 1 |